血清红蛋白及其决定因素和协会在患有血红蛋白E β-thalassaemia的患者中
Dinusha Amarasingha1, Shiromi Perera2, Anuja Premawardhena3,4
1Department of Medical Laboratory Sciences, University of Ruhuna, Matara, Sri Lanka.
Scientific reports
|October 23, 2025
概括
红素水平在HbEβ-thalassaemia中升高,但随着年龄的增长和脊髓切除术后会降低. 下层红色素与血液溶解和贫血并发症的增加有关.
科学领域:
- 血液学 血液学 血液学
- 内分泌学 在内分泌学.
- 遗传学 是一个遗传学.
背景情况:
- 红色素 (EPO) 对于红细胞的产生至关重要.
- HbE β-thalassaemia的病理生理学,一种血红蛋白病变,涉及复杂的相互作用.
- 在HbEβ-thalassaemia中EPO的特定作用仍未得到充分研究.
研究的目的:
- 调查HbE β-thalassaemia患者中红色素水平的决定因素和关联.
- 了解EPO,临床参数和这组患者并发症之间的关系.
主要方法:
- 进行了一项横截面研究,涉及52名HbEβ-thalassaemia患者.
- 收集和分析了临床数据,血红蛋白,费里丁和红蛋白水平.
- 在患者和健康对照者之间比较了红素水平,并检查了与年龄,脊髓切除术和并发症的关联.
主要成果:
- 与对照组相比,HbE β-thalassaemia 患者的血红素平均水平显著更高 (137 与 21.2 mIU/mL 相比).
- 随着年龄的增长,红素水平显著下降 (r = -0.34,p < 0.05),并且在脊髓切除术患者中较低 (中位数为40对129mIU/mL).
- 较低的红色素水平与更高的血液溶解和贫血相关并发症的患病率有关,包括胆结石 (p = 0.039).
结论:
- 在HbEβ-thalassaemia中,红素的响应随着年龄的增长而降低,并且在脊髓切除术后更低.
- 血红素水平降低,可能是由于年龄或脊髓切除术,与血液溶解和贫血并发症的增加相关.
- 这些发现凸显了红色素在HbE β-thalassaemia病理生理学和疾病管理中的复杂作用.
关键词:
红色蛋白质是一种人造蛋白质.胆结石 胆结石 胆结石血红蛋白 E β-thalassaemia 血红蛋白 E β-thalassaemia 血红蛋白 E 血红蛋白 E 血红蛋白 E 血红蛋白 E 血红蛋白 E 血红蛋白 E 血红蛋白 E 血红蛋白脊椎切除术 (Splenectomy) 是一个切除脊椎的方法.泰拉塞米亚症的发生.更多相关视频
07:24A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
1.9K
08:53Author Spotlight: Advancing Erythropoiesis Research - A Simplified Pipeline for Assessing Hematopoietic Stem Cell Function in Myelodysplastic Syndromes
Published on: January 10, 2025
895
相关概念视频
Factors Affecting Erythropoiesis
5.4K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
5.4K
Erythropoiesis
5.7K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
5.7K
Role of Hematopoietic Growth Factors
3.1K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
3.1K
Disorders of Erythrocytes
2.0K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
2.0K
Factors Affecting Protein-Drug Binding: Patient-Related Factors
302
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
302
Multiple Allele Traits
37.9K
The Concept of Multiple Allelism
37.9K
